MiNK Therapeutics INKT
NASDAQ INKT
$10.06 -0.56 (-5.27%)
At close: Oct 22, 2026 · 4:00 PM EDT

MiNK Therapeutics (INKT) Return on Equity [ROE] (2022)

Updated

MiNK Therapeutics' Return on Equity [ROE] was -974.07% in Q4 2022, down 678.38 percentage points from the prior quarter.

Analysis

MiNK Therapeutics (INKT) Return on Equity [ROE] (2022) Analysis & Trends

For FY2022, Return on Equity [ROE] at MiNK Therapeutics came in at -264.80%.

  • Per Business Quant data, INKT's Return on Equity [ROE] in the three quarters before Q4 2022 was -295.68% (Q3 2022), -235.48% (Q2 2022) and -167.52% (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 19.33%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 7.21%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 31.52%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 21.39%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 83.75%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -18.38%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 4.97%
10 MiNK Therapeutics 51.27 Mn 10.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -974.07%
Sep 30, 2022 -295.68%
Jun 30, 2022 -235.48%
Mar 31, 2022 -167.52%
API Access

MiNK Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=INKT&period=max&api_key=YOUR_API_KEY